1.Research Progress of Neutrophil Extracellular Traps in Lung Cancer.
Xu HAO ; Yilin FENG ; Anqi LU ; Ying SUN ; Jinchan XIA ; Xue MEI ; Long FENG ; Min JIANG ; Baiyan WANG ; Huitong YANG
Chinese Journal of Lung Cancer 2025;28(3):201-212
Neutrophil extracellular traps (NETs), intricate reticular structures released by activated neutrophils, play a pivotal regulatory role in the pathogenesis of malignant tumors. Lung cancer is one of the most prevalent malignancies globally, with persistently high incidence and mortality rates. Recent studies have revealed that NETs dynamically modulate the tumor microenvironment through unique pathological mechanisms, exhibiting complex immunoregulatory characteristics during the progression of lung cancer, and this discovery has increasingly become a focal point in tumor immunology research. This paper provides a comprehensive review of the latest advancements in NETs research related to lung cancer, offering an in-depth analysis of their impact on lung cancer progression, their potential diagnostic value, and the current state of research on targeting NETs for lung cancer prevention and treatment. The aim is to propose novel strategies to enhance therapeutic outcomes and improve the prognosis for lung cancer patients.
.
Extracellular Traps/immunology*
;
Humans
;
Lung Neoplasms/metabolism*
;
Neutrophils/metabolism*
;
Animals
;
Tumor Microenvironment
2.Expert consensus on orthodontic treatment of protrusive facial deformities.
Jie PAN ; Yun LU ; Anqi LIU ; Xuedong WANG ; Yu WANG ; Shiqiang GONG ; Bing FANG ; Hong HE ; Yuxing BAI ; Lin WANG ; Zuolin JIN ; Weiran LI ; Lili CHEN ; Min HU ; Jinlin SONG ; Yang CAO ; Jun WANG ; Jin FANG ; Jiejun SHI ; Yuxia HOU ; Xudong WANG ; Jing MAO ; Chenchen ZHOU ; Yan LIU ; Yuehua LIU
International Journal of Oral Science 2025;17(1):5-5
Protrusive facial deformities, characterized by the forward displacement of the teeth and/or jaws beyond the normal range, affect a considerable portion of the population. The manifestations and morphological mechanisms of protrusive facial deformities are complex and diverse, requiring orthodontists to possess a high level of theoretical knowledge and practical experience in the relevant orthodontic field. To further optimize the correction of protrusive facial deformities, this consensus proposes that the morphological mechanisms and diagnosis of protrusive facial deformities should be analyzed and judged from multiple dimensions and factors to accurately formulate treatment plans. It emphasizes the use of orthodontic strategies, including jaw growth modification, tooth extraction or non-extraction for anterior teeth retraction, and maxillofacial vertical control. These strategies aim to reduce anterior teeth and lip protrusion, increase chin prominence, harmonize nasolabial and chin-lip relationships, and improve the facial profile of patients with protrusive facial deformities. For severe skeletal protrusive facial deformities, orthodontic-orthognathic combined treatment may be suggested. This consensus summarizes the theoretical knowledge and clinical experience of numerous renowned oral experts nationwide, offering reference strategies for the correction of protrusive facial deformities.
Humans
;
Orthodontics, Corrective/methods*
;
Consensus
;
Malocclusion/therapy*
;
Patient Care Planning
;
Cephalometry
3.Discussion on the Experimental Animal Model of Adenoid Hypertrophy from the Perspective of Predictive Validity
Yixing ZHANG ; Anqi LIU ; Chenghui SUN
Journal of Zhejiang Chinese Medical University 2025;49(2):132-140
[Objective]To evaluate the feasibility of animal model of simulated adenoid hypertrophy by combining animal model of allergic rhinitis and chronic pharyngitis from the perspective of predictive validity.[Methods]Forty SD rats were randomly divided into blank group,model control group,montelukast group and traditional Chinese medicine(TCM)group,with 10 rats in each group.The model control group,montelukast group and TCM group all established rat model of allergic rhinitis and the rat model of chronic pharyngitis was also established in the same time,which combined the simulated adenoid hypertrophy rat model,while the blank group was replaced the equivalent amount of 0.9%sodium chloride solution.After molding,the montelukast group was gavaged with montelukast sodium particles,the TCM group was gavaged with Yunpi Huatan Tongqiao Decoction,model control group and blank group received equal amount of 0.9%sodium chloride solution,the course of treatment would all be 8 weeks.After molding and after the course of treatment,the symptom performance of model animals was assessed by animal behavioral score and the eosinophil percentage(EOS%),interleukin-4(IL-4),immunoglobulin E(IgE)and hypoxia-inducible factor-1α(HIF-1α)levels in blood serum and nasopharyngeal mucosal tissues were tested,and the pathomorphological changes of nasal and pharyngeal mucosa were observed by hematoxylin-eosin(HE)staining.[Results]After molding,the levels of animal behavioral score,EOS%,serum and tissue IL-4,IgE,and HIF-1α level in model control group,montelukast group and TCM group were significantly upregulated compared with blank group(P<0.01),and the nasal and pharyngeal mucosa showed different degrees of disease-related histopathological changes.After treatment,the levels of each index in montelukast group and TCM group were lower compared with that before treatment,and were also lower than that in model control group,all differences were statistically significant(P<0.05,P<0.01),and the histopathological damage was relieved than before the treatment.[Conclusion]The simulated rat model is similar to adenoid hypertrophy in terms of symptom manifestations and pathological changes,and effective drugs used clinically have similar efficacy in simulated rat models.In terms of predictive validity,the animal model of simulated adenoid hypertrophy can be made by combining animal model of allergic rhinitis and chronic pharyngitis,but it still needs further exploration and improvement.
4.Brain-derived neurotrophic factor and skin diseases
Chinese Journal of Dermatology 2025;58(2):190-193
Brain-derived neurotrophic factor (BDNF), a protein involved in the survival, growth and maintenance of neurons, plays an important role in pathophysiological processes in various neuropsychiatric diseases. In recent years, attention has been widely paid to the roles of BDNF in regulating immunity and participating in inflammatory reactions in non-nervous systems, and more and more studies have shown that BDNF plays an important role in various skin diseases, such as atopic dermatitis, connective tissue diseases and skin tumors. This review summarizes research advances in the role of BDNF in relevant skin diseases.
5.Single-nucleus transcriptomics decodes the link between aging and lumbar disc herniation.
Min WANG ; Zan HE ; Anqi WANG ; Shuhui SUN ; Jiaming LI ; Feifei LIU ; Chunde LI ; Chengxian YANG ; Jinghui LEI ; Yan YU ; Shuai MA ; Si WANG ; Weiqi ZHANG ; Zhengrong YU ; Guang-Hui LIU ; Jing QU
Protein & Cell 2025;16(8):667-684
Lumbar disc (LD) herniation and aging are prevalent conditions that can result in substantial morbidity. This study aimed to clarify the mechanisms connecting the LD aging and herniation, particularly focusing on cellular senescence and molecular alterations in the nucleus pulposus (NP). We performed a detailed analysis of NP samples from a diverse cohort, including individuals of varying ages and those with diagnosed LD herniation. Our methodology combined histological assessments with single-nucleus RNA sequencing to identify phenotypic and molecular changes related to NP aging and herniation. We discovered that cellular senescence and a decrease in nucleus pulposus progenitor cells (NPPCs) are central to both processes. Additionally, we found an age-related increase in NFAT1 expression that promotes NPPC senescence and contributes to both aging and herniation of LD. This research offers fresh insights into LD aging and its associated pathologies, potentially guiding the development of new therapeutic strategies to target the root causes of LD herniation and aging.
Intervertebral Disc Displacement/metabolism*
;
Humans
;
Aging/pathology*
;
Nucleus Pulposus/pathology*
;
Male
;
Female
;
Transcriptome
;
Middle Aged
;
Lumbar Vertebrae/pathology*
;
Adult
;
Cellular Senescence
;
Stem Cells/pathology*
;
Aged
;
Intervertebral Disc Degeneration/metabolism*
6.Survival advantage of first-line chemoimmunotherapy combined with radiotherapy for advanced esophageal squamous cell carcinoma: A propensity score matching analysis
Peixin FENG ; Qing HOU ; Ningning YAO ; Wenjuan ZHANG ; Bochen SUN ; Wenxia NIU ; Anqi ZHAO ; Wenlu CHEN ; Baixue WU ; Yuying ZHOU ; Yiwen ZHANG ; Yu LIANG ; Xin CAO ; Wei BAI ; Jianting LIU ; Shuangping ZHANG ; Jianzhong CAO
Chinese Journal of Radiological Medicine and Protection 2025;45(8):766-773
Objective:To investigate the efficacy of radiotherapy in patients with advanced esophageal cancer receiving first-line chemoimmunotherapy.Methods:A retrospective analysis was conducted on the data of 137 patients with Stage Ⅳ esophageal squamous cell carcinoma (ESCC) treated at our hospital from January 2018 to May 2023. These patients were divided into two groups: a group treated with first-line chemoimmunotherapy combined with radiotherapy (chemoimmunotherapy + radiotherapy group, n = 43) and a group treated with only chemoimmunotherapy ( n = 94). Inverse probability of treatment weighting (IPTW) was applied to balance baseline characteristics between the groups. With overall survival (OS) and progression-free survival (PFS) as study endpoints, the survival data were analyzed using the Kaplan-Meier method, the log-rank test, and the Cox regression method. Results:Before calibration, the chemoimmunotherapy + radiotherapy group significantly outperformed the sole chemoimmunotherapy group in median PFS (13.6 months vs. 7.0 months; HR: 0.501, 95% CI: 0.309-0.811, P = 0.005). After calibration using the COX proportional-hazards model for age, gender, Eastern Cooperative Oncology Group (ECOG) performance status, smoking history, T/N/M stage, and tumor location, the chemoimmunotherapy + radiotherapy group still had significant advantages in PFS (14.7 months vs. 7.0 months; HR: 0.441, 95% CI: 0.261-0.745, P = 0.002). IPTW analysis further confirmed this trend (13.9 months vs. 7.0 months; HR: 0.492, 95% CI: 0.304-0.795, P < 0.001). Specifically, the median OS of the chemoimmunotherapy + radiotherapy group demonstrated significant improvement in all analyses: pre-calibration (29.5 months vs. 18.0 months; HR: 0.507, 95% CI: 0.297-0.867, P = 0.013), after calibration using the Cox model (27.5 months vs. 16.7 months; HR: 0.470, 95% CI: 0.266-0.830, P = 0.009), and after calibration using IPTW (29.5 months vs. 16.9 months; HR: 0.448, 95% CI: 0.262-0.764, P < 0.001). Conclusions:The combination of radiotherapy and first-line chemoimmunotherapy can significantly improve survival outcomes of patients with advanced ESCC, suggesting its potential as a standard treatment strategy.
7.Brain-derived neurotrophic factor and skin diseases
Chinese Journal of Dermatology 2025;58(2):190-193
Brain-derived neurotrophic factor (BDNF), a protein involved in the survival, growth and maintenance of neurons, plays an important role in pathophysiological processes in various neuropsychiatric diseases. In recent years, attention has been widely paid to the roles of BDNF in regulating immunity and participating in inflammatory reactions in non-nervous systems, and more and more studies have shown that BDNF plays an important role in various skin diseases, such as atopic dermatitis, connective tissue diseases and skin tumors. This review summarizes research advances in the role of BDNF in relevant skin diseases.
8.Survival advantage of first-line chemoimmunotherapy combined with radiotherapy for advanced esophageal squamous cell carcinoma: A propensity score matching analysis
Peixin FENG ; Qing HOU ; Ningning YAO ; Wenjuan ZHANG ; Bochen SUN ; Wenxia NIU ; Anqi ZHAO ; Wenlu CHEN ; Baixue WU ; Yuying ZHOU ; Yiwen ZHANG ; Yu LIANG ; Xin CAO ; Wei BAI ; Jianting LIU ; Shuangping ZHANG ; Jianzhong CAO
Chinese Journal of Radiological Medicine and Protection 2025;45(8):766-773
Objective:To investigate the efficacy of radiotherapy in patients with advanced esophageal cancer receiving first-line chemoimmunotherapy.Methods:A retrospective analysis was conducted on the data of 137 patients with Stage Ⅳ esophageal squamous cell carcinoma (ESCC) treated at our hospital from January 2018 to May 2023. These patients were divided into two groups: a group treated with first-line chemoimmunotherapy combined with radiotherapy (chemoimmunotherapy + radiotherapy group, n = 43) and a group treated with only chemoimmunotherapy ( n = 94). Inverse probability of treatment weighting (IPTW) was applied to balance baseline characteristics between the groups. With overall survival (OS) and progression-free survival (PFS) as study endpoints, the survival data were analyzed using the Kaplan-Meier method, the log-rank test, and the Cox regression method. Results:Before calibration, the chemoimmunotherapy + radiotherapy group significantly outperformed the sole chemoimmunotherapy group in median PFS (13.6 months vs. 7.0 months; HR: 0.501, 95% CI: 0.309-0.811, P = 0.005). After calibration using the COX proportional-hazards model for age, gender, Eastern Cooperative Oncology Group (ECOG) performance status, smoking history, T/N/M stage, and tumor location, the chemoimmunotherapy + radiotherapy group still had significant advantages in PFS (14.7 months vs. 7.0 months; HR: 0.441, 95% CI: 0.261-0.745, P = 0.002). IPTW analysis further confirmed this trend (13.9 months vs. 7.0 months; HR: 0.492, 95% CI: 0.304-0.795, P < 0.001). Specifically, the median OS of the chemoimmunotherapy + radiotherapy group demonstrated significant improvement in all analyses: pre-calibration (29.5 months vs. 18.0 months; HR: 0.507, 95% CI: 0.297-0.867, P = 0.013), after calibration using the Cox model (27.5 months vs. 16.7 months; HR: 0.470, 95% CI: 0.266-0.830, P = 0.009), and after calibration using IPTW (29.5 months vs. 16.9 months; HR: 0.448, 95% CI: 0.262-0.764, P < 0.001). Conclusions:The combination of radiotherapy and first-line chemoimmunotherapy can significantly improve survival outcomes of patients with advanced ESCC, suggesting its potential as a standard treatment strategy.
9.Discussion on the Experimental Animal Model of Adenoid Hypertrophy from the Perspective of Predictive Validity
Yixing ZHANG ; Anqi LIU ; Chenghui SUN
Journal of Zhejiang Chinese Medical University 2025;49(2):132-140
[Objective]To evaluate the feasibility of animal model of simulated adenoid hypertrophy by combining animal model of allergic rhinitis and chronic pharyngitis from the perspective of predictive validity.[Methods]Forty SD rats were randomly divided into blank group,model control group,montelukast group and traditional Chinese medicine(TCM)group,with 10 rats in each group.The model control group,montelukast group and TCM group all established rat model of allergic rhinitis and the rat model of chronic pharyngitis was also established in the same time,which combined the simulated adenoid hypertrophy rat model,while the blank group was replaced the equivalent amount of 0.9%sodium chloride solution.After molding,the montelukast group was gavaged with montelukast sodium particles,the TCM group was gavaged with Yunpi Huatan Tongqiao Decoction,model control group and blank group received equal amount of 0.9%sodium chloride solution,the course of treatment would all be 8 weeks.After molding and after the course of treatment,the symptom performance of model animals was assessed by animal behavioral score and the eosinophil percentage(EOS%),interleukin-4(IL-4),immunoglobulin E(IgE)and hypoxia-inducible factor-1α(HIF-1α)levels in blood serum and nasopharyngeal mucosal tissues were tested,and the pathomorphological changes of nasal and pharyngeal mucosa were observed by hematoxylin-eosin(HE)staining.[Results]After molding,the levels of animal behavioral score,EOS%,serum and tissue IL-4,IgE,and HIF-1α level in model control group,montelukast group and TCM group were significantly upregulated compared with blank group(P<0.01),and the nasal and pharyngeal mucosa showed different degrees of disease-related histopathological changes.After treatment,the levels of each index in montelukast group and TCM group were lower compared with that before treatment,and were also lower than that in model control group,all differences were statistically significant(P<0.05,P<0.01),and the histopathological damage was relieved than before the treatment.[Conclusion]The simulated rat model is similar to adenoid hypertrophy in terms of symptom manifestations and pathological changes,and effective drugs used clinically have similar efficacy in simulated rat models.In terms of predictive validity,the animal model of simulated adenoid hypertrophy can be made by combining animal model of allergic rhinitis and chronic pharyngitis,but it still needs further exploration and improvement.
10.Trends in the distribution of Oncomelania hupensis in forestlands in Songjiang District, Shanghai Municipality from 2009 to 2023
Qi MAO ; Caiying SUN ; Anqi LI ; Weiwei LU ; Xihong LÜ ; Xuehui LU ; Yanjun JIN ; Qing YU
Chinese Journal of Schistosomiasis Control 2024;36(2):165-168
Objective To investigate the changes in distribution of Oncomelania hupensis snails in forestlands in Songjiang District, Shanghai Municipality from 2009 to 2023, so as to provide insights into formulation of O. hupensis snail surveillance programs. Methods The reports on O. hupensis snail surveillance in Songjiang District, Shanghai Municipality from 2009 to 2023 were collected, and the snail surveillance data in forestlands were extracted. The trends in the proportion of areas with snails in forestlands in total areas with snails, occurrence of frames with living snails and density of living snails were evaluated using a Joinpoint regression model in Songjiang District from 2009 to 2023, and the annual percent change (APC) and average annual percent change (AAPC). Results A total of 40 sites with snails were found in forestlands in 14 administrative villages of 4 townships, Songjiang District, Shanghai Municipality from 2009 to 2023. A total of 39 065 frames were surveyed for snails in settings covering an area of 609 600 m2, and there were 6 084 frames with snails, covering 151 250 m2 snail habitats. A total of 22 210 snails were captured, with the highest density of 260.00 snails/0.1 m2, and 6 262 snails were dissected, with no Schistosoma japonicum infection identified in snails. The proportion of areas with snails in forestlands in total areas with snails appeared a tendency towards a rise in forestlands in Songjiang District, Shanghai Municipality from 2009 to 2023 (APC = AAPC = 24.9%, P > 0.05); however, there were no turning points in the trend curve, with the highest proportion seen in 2009 (53.81%), the lowest in 2011 and 2023 (both 0) and a mean proportion of 24.81%. The occurrence of frames with living snails appeared a tendency towards a rise from 2009 to 2023 (APC = AAPC = 41.5%, P > 0.05); however, there were no turning points in the trend curve, with the highest occurrence in 2009 (53.81%), the lowest in 2011 and 2013 (both 0), and the mean occurrence of 15.57%. In addition, the density of living snails appeared a tendency towards a rise from 2009 to 2023 (APC = AAPC = 55.0%, P > 0.05); however, there were no turning points in the trend curve, with the highest density in 2023 (0.96 snails/0.1 m2), the lowest in 2011 and 2013 (both 0), and a mean density of 0.57 snails/0.1 m2. Conclusions The difficulty in O. hupensis snail control and risk of imported snails appeared a tendency towards a rise in forestlands in Songjiang District, Shanghai Municipality over years from 2009 to 2023. Supervision and assessment prior to seedling transplantation and intensified surveillance post-transplantation are recommended to reduce the risk of O. hupensis snail importation and spread.

Result Analysis
Print
Save
E-mail